Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report
This case highlights the remarkable response of our patient's ACC to treatment with a novel combination of EP and sintilimab combined with anlotinib. Our findings suggest a safe and more effective combination therapeutic option for patients with adrenocortical carcinoma.
Authors
- Wenjing Niu
- Lifeng Niu
- Haimei Zhang
- Zhongshi Qiao (ORCID: https://orcid.org/0000-0003-2275-8181)
- Hua Liang (ORCID: https://orcid.org/0000-0003-3170-6922)
- Zheng Wang (ORCID: https://orcid.org/0009-0000-2459-2213)
- Xuezhen Ma
Institutions
- Qingdao University (CN)
- Weifang Medical University (CN)
- Shandong University of Aeronautics (CN)
- Weifang People's Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Zoucheng People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.3389/fonc.2024.1403762
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.29